Clinical Laserthermia Price To Book vs. Price To Earning
CLS-B Stock | SEK 4.36 0.12 2.83% |
For Clinical Laserthermia profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Clinical Laserthermia to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Clinical Laserthermia Systems utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Clinical Laserthermia's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Clinical Laserthermia Systems over time as well as its relative position and ranking within its peers.
Clinical |
Clinical Laserthermia Price To Earning vs. Price To Book Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Clinical Laserthermia's current stock value. Our valuation model uses many indicators to compare Clinical Laserthermia value to that of its competitors to determine the firm's financial worth. Clinical Laserthermia Systems is number one stock in price to book category among its peers. It also is number one stock in price to earning category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Clinical Laserthermia's earnings, one of the primary drivers of an investment's value.Clinical Price To Earning vs. Price To Book
Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Clinical Laserthermia |
| = | 4.26 X |
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Clinical Laserthermia |
| = | (10.13) X |
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
Clinical Price To Earning Comparison
Clinical Laserthermia is currently under evaluation in price to earning category among its peers.
Clinical Laserthermia Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Clinical Laserthermia, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Clinical Laserthermia will eventually generate negative long term returns. The profitability progress is the general direction of Clinical Laserthermia's change in net profit over the period of time. It can combine multiple indicators of Clinical Laserthermia, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Clinical Laserthermia Systems AB develops and markets therapies, systems, and single-use instruments for thermal treatment of solid cancer tumors in Sweden. Clinical Laserthermia Systems AB has a collaboration agreement with Image Guided Therapy SA to develop and commercialize a software product for MR-generated temperature monitoring and a collaborative license and co-development agreement with MRI Interventions, Inc. to provide navigation and laser ablation platforms for use in spine and neurosurgery. Clinical Laserthermia is traded on Stockholm Stock Exchange in Sweden.
Clinical Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Clinical Laserthermia. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Clinical Laserthermia position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Clinical Laserthermia's important profitability drivers and their relationship over time.
Use Clinical Laserthermia in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Clinical Laserthermia position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Clinical Laserthermia will appreciate offsetting losses from the drop in the long position's value.Clinical Laserthermia Pair Trading
Clinical Laserthermia Systems Pair Trading Analysis
The ability to find closely correlated positions to Clinical Laserthermia could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Clinical Laserthermia when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Clinical Laserthermia - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Clinical Laserthermia Systems to buy it.
The correlation of Clinical Laserthermia is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Clinical Laserthermia moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Clinical Laserthermia moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Clinical Laserthermia can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Clinical Laserthermia position
In addition to having Clinical Laserthermia in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Climate Change Thematic Idea Now
Climate Change
Large and medium sized entities that are committing to fully or partially replace some traditional services or products with renewables sources of energy in order to combat global climate change. The Climate Change theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Climate Change Theme or any other thematic opportunities.
View All Next | Launch |
Additional Tools for Clinical Stock Analysis
When running Clinical Laserthermia's price analysis, check to measure Clinical Laserthermia's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clinical Laserthermia is operating at the current time. Most of Clinical Laserthermia's value examination focuses on studying past and present price action to predict the probability of Clinical Laserthermia's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clinical Laserthermia's price. Additionally, you may evaluate how the addition of Clinical Laserthermia to your portfolios can decrease your overall portfolio volatility.